Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Multiple Myeloma 7Glioma 7Wilms Tumor 6Rhabdoid Tumor 6Osteosarcoma 6Neuroblastoma 6Neoplasm Metastasis 6Leukemia, Myeloid, Acute 6Breast Neoplasms 6Sarcoma 5Neuroectodermal Tumors, Primitive, Peripheral 5Medulloblastoma 5Lymphoma, Non-Hodgkin 5Lung Neoplasms 5Histiocytosis, Langerhans-Cell 5Hepatoblastoma 5Ependymoma 5Rhabdomyosarcoma 4Prostatic Neoplasms 4Myelodysplastic Syndromes 4Lymphoma 4Central Nervous System Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, T-Cell 3Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Sarcoma, Ewing 2Pancreatic Neoplasms 2Ovarian Neoplasms 2

Interventions

Specimen Handling 3pembrolizumab 2Magnetic Resonance Spectroscopy 2Doxorubicin 2Biopsy 2talimogene laherparepvec 1peposertib 1liposomal doxorubicin 1fludarabine 1aldesleukin 1X-Rays 1Radiotherapy 1Radiation 1Nivolumab 1Ipilimumab 1Histamine H2 Antagonists 1Famotidine 1Cyclophosphamide 1CTLA-4 Antigen 1Angptl4 protein, mouse 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Histiocytoma, Malignant Fibrous × X-Rays × 30 days × Clear all
NCT06422806 2026-05-29

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

National Cancer Institute (NCI)

Phase 3 Recruiting
365 enrolled
Sarcoma

Liposarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡